SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.

Szczegóły

Tytuł:: SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.
Autorzy:: Walldorf J; Martin Luther University of Halle-Wittenberg, Department of Internal Medicine I, Halle, Germany.
von Arnim U; Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital, Magdeburg, Germany.
Schmelz R; University Hospital Dresden, Department of Internal Medicine I, TU Dresden, Germany.
Riesner-Wehner A; Martin Luther University of Halle-Wittenberg, Department of Internal Medicine I, Halle, Germany.
Michl P; Martin Luther University of Halle-Wittenberg, Department of Internal Medicine I, Halle, Germany.
Grunert PC; Jena University Hospital, Department of Internal Medicine IV, Jena, Germany.
Stallmach A; Jena University Hospital, Department of Internal Medicine IV, Jena, Germany.
Teich N; Internistische Gemeinschaftspraxis für Verdauungs-und Stoffwechselkrankheiten Leipzig und Schkeuditz, Leipzig, Germany.
Reuken PA; Jena University Hospital, Department of Internal Medicine IV, Jena, Germany.
Źródło:: Inflammatory bowel diseases [Inflamm Bowel Dis] 2021 Oct 20; Vol. 27 (11), pp. 1858-1861.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: 2018- : [Oxford] : Oxford University Press
Original Publication: New York, NY : Raven Press, c1995-
MeSH Terms:: Attitude to Health*
COVID-19*/epidemiology
COVID-19*/prevention & control
Inflammatory Bowel Diseases*/epidemiology
Inflammatory Bowel Diseases*/psychology
Inflammatory Bowel Diseases*/therapy
Patient Acceptance of Health Care*/psychology
Patient Acceptance of Health Care*/statistics & numerical data
Vaccination*/methods
Vaccination*/psychology
COVID-19 Vaccines/*therapeutic use
Directive Counseling/*methods
Adult ; Female ; Germany/epidemiology ; Humans ; Influenza Vaccines/therapeutic use ; Male ; Risk Assessment ; SARS-CoV-2 ; Surveys and Questionnaires
Contributed Indexing:: Keywords: COVID19; IBD; SARS-CoV-2; influenza; vaccination
Substance Nomenclature:: 0 (COVID-19 Vaccines)
0 (Influenza Vaccines)
Entry Date(s):: Date Created: 20210628 Date Completed: 20211102 Latest Revision: 20211102
Update Code:: 20240105
PubMed Central ID:: PMC8344527
DOI:: 10.1093/ibd/izab150
PMID:: 34181021
: Czasopismo naukowe

Informacja